CBLPath
About:
CBLPath is a provider of sub-specialized anatomic pathology and molecular diagnostic laboratory services.
Website: http://cblpath.com
Description:
CBLPath, Inc. is a leading provider of sub-specialized anatomic pathology and molecular diagnostic laboratory services. They are committed to partnering with their physician-clients to provide the best possible patient care. Founded in 1988 as Cytopath Biopsy Lab, their landmark laboratory quickly established a reputation for providing definitive diagnoses coupled with extraordinary customer service.
Total Funding Amount:
$3.2M
Estimated Revenue Range:
$50M to $100M
Headquarters Location:
Ocala, Florida, United States
Founded Date:
1988-01-01
Founders:
Carlos Urmacher, David McGinnis
Number of Employees:
51-100
Last Funding Date:
2010-03-31
IPO Status:
Private
Industries:
© 2025 bioDAO.ai